Moderna, Pfizer Won’t Attend White House Summit on Vaccines
- Both drugmakers have pending clearance applications at FDA
- With FDA officials attending summit, concern about conflicts
This article is for subscribers only.
Pfizer Inc. and Moderna Inc., the two pharmaceutical companies closest to gaining U.S. clearance for a Covid-19 vaccine, won’t attend a White House summit intended to build confidence in the shots.
With the Food and Drug Administration expected to decide on whether to allow the companies’ vaccines to be distributed in the coming days, there was worry that regulators and executives shouldn’t be seen rubbing elbows at the Tuesday meeting.